Stay updated on Psilocybin-Induced Neuroplasticity in MDD Clinical Trial
Sign up to get notified when there's something new on the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page.

Latest updates to the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check8 days agoChange DetectedThe site revision label in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe study page is now displaying a 403 Forbidden error instead of the prior content, replacing the study details with an access-denied page. This suggests restricted access or a site misconfiguration that hides the original page content and navigation.SummaryDifference18%

- Check43 days agoChange DetectedThe page shows a new revision entry v3.6.6, replacing v3.6.5, indicating a version update to the study record. This update appears to be maintenance rather than a substantive change to the study details.SummaryDifference0.1%

- Check72 days agoChange DetectedRevision tag updated from v3.6.4 to v3.6.5, indicating a new page version. This update is a metadata change and does not alter the study details or results presented.SummaryDifference0.1%

- Check86 days agoChange DetectedRevision tag changed from v3.6.3 to v3.6.4 on the page, signaling a new revision of the study record in ClinicalTrials.gov.SummaryDifference0.1%

Stay in the know with updates to Psilocybin-Induced Neuroplasticity in MDD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin-Induced Neuroplasticity in MDD Clinical Trial page.